Authors


Gene Usdin, MD

Latest:

Famous Marriages: What They Can Teach Us

This book is recommended not only for therapists but also for patients in therapy and others seeking enjoyable, fascinating reading and insight into their own marital relationships.


Geoffrey D. Carr, PhD

Latest:

Psychotherapy Research

For prescribing psychiatrists who want to offer treatment alternatives to patients who prefer to avoid medication, the evidence is clear that psychotherapy is an effective choice. Even in cases in which medication is accepted, the evidence suggests that psychotherapy may significantly improve patient outcomes.


Georg Northoff, MD, PhD

Latest:

Psychopathology and Pathophysiology of Depression

Is depression a systemic disorder of oneself and the brain’s intrinsic activity?


George Dawson, MD

Latest:

Epistemic Humility in Psychiatry: Why We Need More Montaigne and Less Savonarola

Delve into the imperative of embracing epistemic humility in psychiatry.


George E. Woody, MD

Latest:

Addiction, AIDS, and NIDA’s Overseas Program

A report on substance abuse and HIV research around the world.


George Ferenczi, MD, MBA

Latest:

'I Feel I Am Successful When…'

Gastroenterologist George Ferenczi escaped the Iron Curtain as a boy. Now he tries to justify his luck, and life.


George Hutton, MD

Latest:

Multiple Sclerosis: MRI in Diagnosis, Management, and Monitoring

MRI has provided important insights into the pathophysiology of multiple sclerosis (MS).1 However, conventional MRI scans furnish only gross estimates of the nature and extent of tissue damage associated with MS,2 and the data correlate poorly with measures of concurrent disability in patients.


George I. Papakostas, MD

Latest:

Treatment-Resistant Major Depressive Disorder: New Developments in 2006

Despite the progressive increase in the number of available antidepressants, many patients with depression continue to be symptomatic.


George Loeffler, MD

Latest:

A First-Episode Psychosis Treatment Program: “The Disease Doesn’t Define Me”

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.


George Mckinley, MD

Latest:

Frontolobular Cystic Mass and Hydrocephalus in Woman With Headache and Lethargy

A previously healthy 35-year-old woman was admitted to a New York City hospital after presenting to the emergency department (ED) with a 10- to 14-day history of generalized weakness, progressive frontal headache, and lethargy. She immigrated to Brooklyn, New York, from urban Haiti 9 years previously and had not returned to Haiti since. She denied any recent travel elsewhere and had no pets. An HIV antibody test, performed 4 months before ED presentation, was negative.


George Mecouch, DO

Latest:

The Arms of Ivy Welcome Her

With the help of psychotherapy, something from the deep unconscious helped cure her depression, forge her character, and guide her to a sense of peace.


George Michael Viola, MD

Latest:

Frontolobular Cystic Mass and Hydrocephalus in Woman With Headache and Lethargy

A previously healthy 35-year-old woman was admitted to a New York City hospital after presenting to the emergency department (ED) with a 10- to 14-day history of generalized weakness, progressive frontal headache, and lethargy. She immigrated to Brooklyn, New York, from urban Haiti 9 years previously and had not returned to Haiti since. She denied any recent travel elsewhere and had no pets. An HIV antibody test, performed 4 months before ED presentation, was negative.


George Simpson, MD

Latest:

Treatment-Resistant Schizophrenia: Making the Determination

Several confounding factors need to be taken into account before labeling a patient as treatment-resistant. What options are available for treating a patient with schizophrenia who has been diagnosed as such?


George Stricker, PhD

Latest:

An Introduction to Psychotherapy Integration

There are three types of integration practiced by psychotherapists: Common Factors, Assimilative Integration and Theoretical Integration. How do they differ from each other, and how does psychotherapy integration differ from an eclectic approach to therapy?


Georgeann Neuzil, MS

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.


Gerald A. Maguire, MD

Latest:

Pseudobulbar Affect Versus Depression: Issues in Diagnosis and Treatment

The most challenging aspect of pseudobulbar affect is differentiating it from depression. Episodes of uncontrollable, sudden, and even inappropriate emotions may point to neurologic or psychiatric conditions.


Gerald O'Malley, DO

Latest:

Rika the Riveter

My wife, Rika, has completed six years of excruciating residency, passed the board exam the first time that she took it and is completing a similarly demanding medical toxicology fellowship now. She is raising our two beautiful children, works in a dangerous, hostile, challenging inner city ER, teaches, does research, refuses to hire a housekeeper yet keeps the house running like clockwork and puts up with me and all my crap.


Gerald Schneiderman, MD

Latest:

Sixty-Five Years After World War II: A Family Secret

The Holocaust is well known and has been well researched. The purpose of this study was to evaluate persons 65 years after the Holocaust who remained in Poland and discovered the “secret” of their Jewish ancestry, despite not being raised as Jews.


Gerald Valentine, MD

Latest:

MDMA and Ecstasy

Although there are numerous media accounts of the detrimental effects of the drug Ecstasy, there may also be some clinical uses in the treatment of PTSD. The U.S. Food and Drug Administration has approved the first-ever clinical trial of MDMA since it was banned in 1988. An expert in the field discusses what psychiatrists need to know about the popular "rave" drug and the compound's use as a therapeutic tool.


Gerald W. Keister

Latest:

The Huntington's Disease Society of America: Dedicated to Education and Care

Huntington disease (HD) is a devastating hereditary, degenerative brain disorder for which there is, at present, no effective treatment or cure. More than a quarter of a million Americans have HD or are at risk for the disease because of potential genetic transmission. The disease slowly diminishes the affected person's ability to walk, think, talk, and reason. As it progresses, concentration and short-term memory diminish and involuntary movements of the head, trunk, and limbs increase.


Gerard Sanacora, MD, PhD

Latest:

ECT and Ketamine/Esketamine: Guiding Clinical Practice

ECT: a gold-standard treatment for major depressive disorder. Ketamine/esketamine: a newer therapeutic option. This ACNP 2023 Annual Meeting session took a deeper look.


Gerhard Gründer, MD

Latest:

Psychotropic Drugs: Brain and Plasma Pharmacokinetics and the Therapeutic Window

Administering drug dosages that are clinically effective while causing minimal side effects is a challenge for physicians. The latest data on antipsychotics, antidepressants, and other psychotropic drugs in relation to brain occupancy and plasma levels are reviewed here.


Giancarlo Dimaggio, MD

Latest:

10 Things to Know About Narcissistic Personality Disorder

Lack of empathy is a commonly known feature of narcissistic personality disorder. Relationships are typically shallow and difficult to maintain. What are some other features of NPD? More in this case presentation.


Gianni L. Faedda, MD

Latest:

“Switching” of Mood From Depression to Mania With Antidepressants

Mood switching is not uncommon and it is much more prevalent in depressed juveniles than in depressed adults, and there is a large apparent excess of antidepressant-associated switching over reported spontaneous diagnostic changes to bipolar disorder. Details here.


Gil D. Hoftman, MD, PhD

Latest:

The Freedom in Accepting Our Limits

A psychiatrist realizes he is completely powerless against his patient's opiate addiction.


Gilbert Kliman, MD

Latest:

Working With Traumatized Patients

There are feasible and replicable ways for caring adults to help heal themselves as well as the next generation through mass application of reflection and altruistic caring for the remaining offspring, whether in Sichuan, Gaza, New Orleans, or Haiti.


Gin S. Malhi, MD

Latest:

Lithium Therapy, Bipolar Disorder- and Neurocognition

Functional mood stability can be attained with lithium therapy, but guidelines on how to get there have become increasingly sophisticated.


Gina Agredano, MD

Latest:

Prevalence and Consequences of Metabolic Syndrome in Bipolar Disorder

Medications used in the treatment of bipolar disorder are commonly associated with weight gain. Antipsychotic drugs have been implicated in new-onset diabetes.


Gina Nikkel, PhD

Latest:

How to Fix the Broken Mental Health System: Ten Crucial Changes

The Foundation for Excellence in Mental Health Care suggests a total redesign of the mental health system from the federal level down to the local level. Three overarching themes are articulated.


Giorgio Corretti, MD

Latest:

The Relationship Between Anxiety Disorders and Sexual Dysfunction

In this article, we examine the relationship between anxiety disorders and SDs, using DSM-IV-TR categories, although we are conscious of the limits of this approach. In doing so, we will consider not only the dichotomy between normal and pathological functioning but also the issue of sexual satisfaction as part of wellness.

© 2024 MJH Life Sciences

All rights reserved.